Literature DB >> 15128428

Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.

Samo Zver, Dusan Andoljsek, Peter Cernelc.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15128428     DOI： 10.1111/j.1600-0609.2004.00237.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  5 in total

Review 1.  How I treat children and adolescents with acute promyelocytic leukaemia.

Authors:  Oussama Abla; Raul C Ribeiro
Journal:  Br J Haematol       Date:  2013-09-30       Impact factor: 6.998

Review 2.  Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all.

Authors:  Maximilian Stahl; Martin S Tallman
Journal:  Leuk Lymphoma       Date:  2019-12-16

3.  Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH.

Authors:  Tzu-Fei Wang; Robert S Makar; Darko Antic; Jerrold H Levy; James D Douketis; Jean M Connors; Marc Carrier; Jeffrey I Zwicker
Journal:  J Thromb Haemost       Date:  2020-12       Impact factor: 5.824

4.  Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias.

Authors:  Gülsüm Emel Pamuk; Murat Taşçi; Erman Oztürk; Muzaffer Demir
Journal:  Med Oncol       Date:  2009-01-10       Impact factor: 3.064

Review 5.  Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia.

Authors:  Mengyu Xiao; Pan Zhou; Kai Sun
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.